{"id":39358,"date":"2026-07-06T08:13:21","date_gmt":"2026-07-06T06:13:21","guid":{"rendered":"https:\/\/ggba.swiss\/ac-immune-secures-usd-4-million-grant-to-advance-its-parkinsons-immunotherapy\/"},"modified":"2026-07-06T08:16:21","modified_gmt":"2026-07-06T06:16:21","slug":"ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson","status":"publish","type":"post","link":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/","title":{"rendered":"AC Immune d\u00e9croche USD 4 millions pour faire avancer son immunoth\u00e9rapie contre Parkinson"},"content":{"rendered":"\n

AC Immune<\/a>, une entreprise biopharmaceutique de stade clinique bas\u00e9e \u00e0 Lausanne, recevra un don de recherche de USD 4 millions de la Vijay and Marie Goradia Charitable Foundation. Ce don soutiendra la prolongation de la premi\u00e8re partie de l’essai de phase 2 VacSYn en cours d’ACI-7104, l’immunoth\u00e9rapie active anti-alpha-synucl\u00e9ine de l’entreprise contre la maladie de Parkinson \u00e0 un stade pr\u00e9coce.<\/p>\n\n\n\n

La prolongation pr\u00e9vue \u00e9valuera la s\u00e9curit\u00e9 et l’efficacit\u00e9 \u00e0 long terme d’ACI-7104 sur deux ann\u00e9es suppl\u00e9mentaires, g\u00e9n\u00e9rant des donn\u00e9es particuli\u00e8rement pr\u00e9cieuses pour les patients aux stades prodromique et pr\u00e9coce de la maladie de Parkinson, susceptibles de n\u00e9cessiter un traitement prolong\u00e9. Les donn\u00e9es finales de la premi\u00e8re partie de l’essai sont attendues au second semestre 2026.<\/p>\n\n\n\n

ACI-7104 est con\u00e7u pour g\u00e9n\u00e9rer une r\u00e9ponse anticorps cibl\u00e9e contre les formes pathologiques de l’alpha-synucl\u00e9ine, une prot\u00e9ine dont l’accumulation contribue \u00e0 la d\u00e9g\u00e9n\u00e9rescence des neurones dans la maladie de Parkinson. Les r\u00e9sultats interm\u00e9diaires positifs publi\u00e9s en d\u00e9cembre 2025 sugg\u00e9raient que cibler la pathologie de l’alpha-synucl\u00e9ine pourrait avoir un effet modificateur de la maladie et ralentir sa progression, avec un profil de s\u00e9curit\u00e9 favorable et des signes d’engagement de la cible.<\/p>\n\n\n\n

Fond\u00e9e et bas\u00e9e \u00e0 Lausanne, AC Immune est un leader mondial des th\u00e9rapies de pr\u00e9cision contre les maladies neurod\u00e9g\u00e9n\u00e9ratives, dont la maladie d’Alzheimer et la maladie de Parkinson. Ses deux plateformes valid\u00e9es cliniquement, SupraAntigen et Morphomer, alimentent un pipeline qui a conclu des partenariats strat\u00e9giques avec de grandes entreprises pharmaceutiques et repr\u00e9sente plus de USD 4,5 milliards de paiements d’\u00e9tape potentiels.<\/p>\n","protected":false},"excerpt":{"rendered":"

AC Immune recevra un don de recherche de USD 4 millions la Vijay and Marie Goradia Charitable Foundation pour prolonger la premi\u00e8re partie de l’essai de phase 2 VacSYn d’ACI-7104, son immunoth\u00e9rapie contre la maladie de Parkinson \u00e0 un stade pr\u00e9coce.<\/p>\n","protected":false},"author":6,"featured_media":39355,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[843],"tags":[1169,1148,1188,1239,1142],"class_list":["post-39358","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-sciences-de-la-vie","tag-biotech-fr-2","tag-financing-fr-2","tag-healthcare-fr-2","tag-neuroscience-fr-2","tag-rd-fr-2"],"acf":[],"yoast_head":"\nAC Immune d\u00e9croche 4 M USD contre Parkinson | GGBa<\/title>\n<meta name=\"description\" content=\"AC Immune d\u00e9croche un don de recherche de USD 4M de la Fondation Goradia pour prolonger l'essai de son immunoth\u00e9rapie contre Parkinson.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AC Immune d\u00e9croche 4 M USD contre Parkinson | GGBa\" \/>\n<meta property=\"og:description\" content=\"AC Immune d\u00e9croche un don de recherche de USD 4M de la Fondation Goradia pour prolonger l'essai de son immunoth\u00e9rapie contre Parkinson.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/\" \/>\n<meta property=\"og:site_name\" content=\"Greater Geneva Bern area\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-06T06:13:21+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-06T06:16:21+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ggba.swiss\/app\/uploads\/2026\/07\/AC-Immune-Parkinson-2026-1180x811-1.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1180\" \/>\n\t<meta property=\"og:image:height\" content=\"811\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Pierre-Yves Oehrli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Pierre-Yves Oehrli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/\"},\"author\":{\"name\":\"Pierre-Yves Oehrli\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"headline\":\"AC Immune d\u00e9croche USD 4 millions pour faire avancer son immunoth\u00e9rapie contre Parkinson\",\"datePublished\":\"2026-07-06T06:13:21+00:00\",\"dateModified\":\"2026-07-06T06:16:21+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/\"},\"wordCount\":308,\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/07\/AC-Immune-Parkinson-2026-1180x811-1.png\",\"keywords\":[\"Biotech\",\"Financing\",\"Healthcare\",\"Neuroscience\",\"R&D\"],\"articleSection\":[\"Sciences de la vie\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/\",\"url\":\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/\",\"name\":\"AC Immune d\u00e9croche 4 M USD contre Parkinson | GGBa\",\"isPartOf\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/07\/AC-Immune-Parkinson-2026-1180x811-1.png\",\"datePublished\":\"2026-07-06T06:13:21+00:00\",\"dateModified\":\"2026-07-06T06:16:21+00:00\",\"author\":{\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\"},\"description\":\"AC Immune d\u00e9croche un don de recherche de USD 4M de la Fondation Goradia pour prolonger l'essai de son immunoth\u00e9rapie contre Parkinson.\",\"breadcrumb\":{\"@id\":\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#primaryimage\",\"url\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/07\/AC-Immune-Parkinson-2026-1180x811-1.png\",\"contentUrl\":\"https:\/\/ggba.swiss\/app\/uploads\/2026\/07\/AC-Immune-Parkinson-2026-1180x811-1.png\",\"width\":1180,\"height\":811,\"caption\":\"AC Immune d\u00e9veloppe des immunoth\u00e9rapies de pr\u00e9cision contre les maladies neurod\u00e9g\u00e9n\u00e9ratives, dont son candidat ACI-7104 pour la maladie de Parkinson \u00e0 un stade pr\u00e9coce.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ggba.swiss\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AC Immune d\u00e9croche USD 4 millions pour faire avancer son immunoth\u00e9rapie contre Parkinson\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#website\",\"url\":\"https:\/\/staging.ggba.swiss\/en\/\",\"name\":\"Greater Geneva Bern area\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41\",\"name\":\"Pierre-Yves Oehrli\",\"url\":\"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"AC Immune d\u00e9croche 4 M USD contre Parkinson | GGBa","description":"AC Immune d\u00e9croche un don de recherche de USD 4M de la Fondation Goradia pour prolonger l'essai de son immunoth\u00e9rapie contre Parkinson.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/","og_locale":"fr_FR","og_type":"article","og_title":"AC Immune d\u00e9croche 4 M USD contre Parkinson | GGBa","og_description":"AC Immune d\u00e9croche un don de recherche de USD 4M de la Fondation Goradia pour prolonger l'essai de son immunoth\u00e9rapie contre Parkinson.","og_url":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/","og_site_name":"Greater Geneva Bern area","article_published_time":"2026-07-06T06:13:21+00:00","article_modified_time":"2026-07-06T06:16:21+00:00","og_image":[{"width":1180,"height":811,"url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/07\/AC-Immune-Parkinson-2026-1180x811-1.png","type":"image\/png"}],"author":"Pierre-Yves Oehrli","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Pierre-Yves Oehrli","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#article","isPartOf":{"@id":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/"},"author":{"name":"Pierre-Yves Oehrli","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"headline":"AC Immune d\u00e9croche USD 4 millions pour faire avancer son immunoth\u00e9rapie contre Parkinson","datePublished":"2026-07-06T06:13:21+00:00","dateModified":"2026-07-06T06:16:21+00:00","mainEntityOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/"},"wordCount":308,"image":{"@id":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/07\/AC-Immune-Parkinson-2026-1180x811-1.png","keywords":["Biotech","Financing","Healthcare","Neuroscience","R&D"],"articleSection":["Sciences de la vie"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/","url":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/","name":"AC Immune d\u00e9croche 4 M USD contre Parkinson | GGBa","isPartOf":{"@id":"https:\/\/staging.ggba.swiss\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#primaryimage"},"image":{"@id":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#primaryimage"},"thumbnailUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/07\/AC-Immune-Parkinson-2026-1180x811-1.png","datePublished":"2026-07-06T06:13:21+00:00","dateModified":"2026-07-06T06:16:21+00:00","author":{"@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41"},"description":"AC Immune d\u00e9croche un don de recherche de USD 4M de la Fondation Goradia pour prolonger l'essai de son immunoth\u00e9rapie contre Parkinson.","breadcrumb":{"@id":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#primaryimage","url":"https:\/\/ggba.swiss\/app\/uploads\/2026\/07\/AC-Immune-Parkinson-2026-1180x811-1.png","contentUrl":"https:\/\/ggba.swiss\/app\/uploads\/2026\/07\/AC-Immune-Parkinson-2026-1180x811-1.png","width":1180,"height":811,"caption":"AC Immune d\u00e9veloppe des immunoth\u00e9rapies de pr\u00e9cision contre les maladies neurod\u00e9g\u00e9n\u00e9ratives, dont son candidat ACI-7104 pour la maladie de Parkinson \u00e0 un stade pr\u00e9coce."},{"@type":"BreadcrumbList","@id":"https:\/\/ggba.swiss\/fr\/ac-immune-decroche-usd-4-millions-pour-faire-avancer-son-immunotherapie-contre-parkinson\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ggba.swiss\/fr\/"},{"@type":"ListItem","position":2,"name":"AC Immune d\u00e9croche USD 4 millions pour faire avancer son immunoth\u00e9rapie contre Parkinson"}]},{"@type":"WebSite","@id":"https:\/\/staging.ggba.swiss\/en\/#website","url":"https:\/\/staging.ggba.swiss\/en\/","name":"Greater Geneva Bern area","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.ggba.swiss\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.ggba.swiss\/en\/#\/schema\/person\/0b2e6d04131e3d01237dcb741fa33d41","name":"Pierre-Yves Oehrli","url":"https:\/\/ggba.swiss\/fr\/author\/pierre-yves-oehrli\/"}]}},"_links":{"self":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39358","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/comments?post=39358"}],"version-history":[{"count":1,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39358\/revisions"}],"predecessor-version":[{"id":39360,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/posts\/39358\/revisions\/39360"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media\/39355"}],"wp:attachment":[{"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/media?parent=39358"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/categories?post=39358"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ggba.swiss\/fr\/wp-json\/wp\/v2\/tags?post=39358"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}